7 Analysts Have This to Say About CVS Health
Portfolio Pulse from Benzinga Insights
Within the last quarter, 7 analysts have provided ratings for CVS Health (NYSE:CVS), all of which are somewhat bullish. The average price target given is $86.43, which is significantly higher than the current price of $68.205, suggesting an implied upside. However, this target is a 5.8% decrease from the previous average price target of $91.75. Analysts typically review stocks each quarter and may adjust their predictions based on various factors, including company performance and market conditions.
November 21, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a somewhat bullish consensus on CVS Health with a reduced average price target of $86.43, suggesting a potential upside from the current price.
The unanimous somewhat bullish rating from analysts indicates a positive sentiment towards CVS Health's stock. The average price target being significantly higher than the current stock price could lead to increased investor confidence and a potential short-term rise in the stock price. However, the reduction in the target price from the previous average may temper expectations slightly.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100